Assignee
ICM CO LTD
KR·3 granted patents·1 pending application·0 citations·filing 2017–2022
Top patents by PatentIndex Score
4 records- 0162US11154590B2Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredientICM CO LTD·Filed 2020·Granted Oct 26, 2021·0 cites·18 claims
- 0257US2023149506A1Pharmaceutical composition for treating retinal dystrophies, comprising nkx3.2 and fragment thereof as active ingredientsICM CO LTD·Filed 2022·Application pending·0 cites
- 0355US11235025B2Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredientICM CO LTD·Filed 2017·Granted Feb 1, 2022·0 cites·15 claims
- 0454US11628203B2Pharmaceutical composition for treating retinal dystrophies, comprising Nkx3.2 and fragment thereof as active ingredientsICM CO LTD·Filed 2018·Granted Apr 18, 2023·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →